Sekisui Diagnostics LLC 1080 OSOM Flu Sars-CoV-2 Combo Test 25

The Sekisui Diagnostics, LLC 1080 OSOM^® Flu Sars-CoV-2 Combo Test is a medical diagnostic tool designed for use in clinical settings, such as hospitals, laboratories, and outpatient clinics. This innovative test stands out for its ability to simultaneously detect and differentiate between influenza A, influenza B, and SARS-CoV-2, providing healthcare professionals with rapid and accurate results to inform patient care and treatment decisions.

This product is an in vitro diagnostic test intended for the qualitative detection of influenza A, influenza B, and SARS-CoV-2 antigens in respiratory specimens. The test is designed to aid in the diagnosis of influenza and COVID-19, enabling healthcare providers to quickly identify infected patients and implement appropriate treatment and infection control measures.

Key Features

• Rapid results: Provides accurate test results in a short amount of time, enabling timely patient care and treatment decisions
• Combo testing: Simultaneously detects and differentiates between influenza A, influenza B, and SARS-CoV-2, reducing the need for multiple tests and streamlining the diagnostic process
• Easy to use: Simple and intuitive test procedure, minimizing the risk of user error and reducing training requirements
• High sensitivity and specificity: Accurately detects influenza and SARS-CoV-2 antigens, ensuring reliable results and confident patient care decisions
• CLIA-waived: Suitable for use in a variety of clinical settings, including those with limited laboratory resources or expertise
• Convenient packaging: Supplied in kits of 25 tests, making it easy to manage inventory and reduce waste
• Rapid diagnosis: Enables healthcare providers to quickly identify infected patients, implement infection control measures, and prevent further transmission

Product Specifications

The test kit * Dimensions: varies by packaging configuration * Weight: approximately 1.5 lbs per kit * Materials: plastic, paper, and other materials compatible with medical device manufacturing * Compliance: meets applicable regulatory requirements for in vitro diagnostic tests, including CLIA-waived status

Ideal For

This product is suitable for use in a variety of clinical settings, including: * Hospitals * Laboratories * Outpatient clinics * Urgent care centers * Physician offices * Public health clinics * Other healthcare facilities where rapid and accurate diagnosis of influenza and SARS-CoV-2 is required.